Simplex Trading
CBIO icon

Simplex Trading’s Crescent Biopharma CBIO Stock Holding History

Simplex Trading’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-343
Closed -$7K – 9038
2025
Q1 		$7K Sell
343
-89
-21% -$2.38K ﹤0.01% 7319
2024
Q4 		$10K Buy
+432
New +$11.8K ﹤0.01% 7181
2024
Q3 		– Sell
-2,417
Closed -$68K – 8888
2024
Q2 		$68K Buy
2,417
+1,518
+169% +$158K ﹤0.01% 5765
2024
Q1 		$269K Buy
899
+722
+408% +$216K ﹤0.01% 4530
2023
Q4 		$41K Sell
177
-35
-17% -$5.44K ﹤0.01% 6278
2023
Q3 		$31K Buy
212
+122
+136% +$19.2K ﹤0.01% 6222
2023
Q2 		$15K Sell
90
-1,027
-92% -$172K ﹤0.01% 7028
2023
Q1 		$140K Buy
1,117
+1,090
+4,037% +$245K ﹤0.01% 4761
2022
Q4 		$8K Buy
+27
New +$3.98K ﹤0.01% 7722
2022
Q2 		– Sell
-49
Closed -$5K – 10346
2022
Q1 		$5K Sell
49
-455
-90% -$53.4K ﹤0.01% 9409
2021
Q4 		$72K Buy
504
+225
+81% +$40.8K ﹤0.01% 6734
2021
Q3 		$64K Hold
279
– – ﹤0.01% 7215
2021
Q2 		$64K Buy
+279
New +$71K ﹤0.01% 7336
2021
Q1 		– Sell
-2
Closed -$716 – 7881
2020
Q4 		$93K Buy
2
+1
+100% +$350 ﹤0.01% 5510
2020
Q3 		$16K Buy
+1
New +$382 ﹤0.01% 6501
2020
Q2 		– Hold
0
– – – 7044
2020
Q1 		– Hold
0
– – – 7182
2019
Q4 		– Sell
-1
Closed -$541 – 5945
2019
Q3 		$27K Hold
1
– – ﹤0.01% 5571
2019
Q2 		$72K Buy
+1
New +$1.2K ﹤0.01% 4512
2019
Q1 		– Hold
0
– – – 6896
2018
Q3 		– Hold
0
– -$6K – 7627
2018
Q2 		– Hold
0
– – – 6614
2018
Q1 		– Hold
0
– – – 5261
2017
Q4 		– Hold
0
– – – 3806
2017
Q3 		– Hold
0
– -$1K – 6149
2017
Q2 		– Hold
0
– – – 5603

Other funds holding CBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
ACPLP
ACT Capital Partners, L.P. Wayne, Pennsylvania $154M AUM
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Simplex Trading's CBIO Position: Q3 2026 in Review

Simplex Trading opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 3,413 shares worth $49.8K. The stake represents ﹤0.01% of the portfolio and ranks #6177 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CBIO as recently as Q1 2024.

Simplex Trading first reported a position in CBIO in Q2 2017 and has held it in 21 quarters since. The position peaked at $280K in Q1 2019. 23 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • Simplex Trading held 3,413 shares of Crescent Biopharma worth $49.8K as of Q3 2026.
  • Crescent Biopharma was a new Simplex Trading position in Q3 2026.
  • Crescent Biopharma made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #6177 holding.
  • Simplex Trading first reported a position in Crescent Biopharma in Q2 2017 and has held it in 21 quarters since.
  • Simplex Trading's Crescent Biopharma position peaked at $280K in Q1 2019.
  • 23 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.